Abbott (NYSE: ABT) Faces Trial Over Claims of Infant Formula-Linked Disease Risks
Similac baby formula maker Abbott (NYSE: ABT) is expected to face a trial on Monday over claims that its formula […]
Abbott (NYSE: ABT) Faces Trial Over Claims of Infant Formula-Linked Disease Risks Read More »